HTA102 Exploring Potential Inequity in Access to Medicines for Ultra-Rare Disease in England and Scotland: SMC Ultra-Orphan Pathway Versus NICE HST
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1786
https://www.valueinhealthjournal.com/article/S1098-3015(23)04916-1/fulltext
Title :
HTA102 Exploring Potential Inequity in Access to Medicines for Ultra-Rare Disease in England and Scotland: SMC Ultra-Orphan Pathway Versus NICE HST
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04916-1&doi=10.1016/j.jval.2023.09.1786
First page :
Section Title :
Open access? :
No
Section Order :
11224